Exhibiting at the 66th Annual Meeting of the Japanese Society of Neurology
Proteobridge Inc. (Headquarters: Tokyo, President and CEO: Ryo Kumagai, hereinafter referred to as “our company”) will exhibit at the 66th Annual Meeting of the Japanese Society of Neurology, which will be held at the Osaka International Convention Center and the Rihga Royal Hotel Osaka from Wednesday, May 21 to Saturday, May 24, 2025, in collaboration with Fushimi Pharmaceutical Co., Ltd.
At this exhibition, we will introduce the latest technologies that support research and clinical applications in the field of neurology, focusing on the biomarker analysis services developed and provided by our company. In particular, we will introduce our efforts to contribute to improving the quality of research on autoimmune diseases and neurological diseases and accelerating drug discovery research through innovative technologies based on proteomics.
When you visit, please stop by our booth (K-15) co-hosted by our company and Fushimi Pharmaceutical Co., Ltd.
[Exhibition details]
■Exhibition name: 66th Annual Meeting of the Japanese Society of Neurology
Official website: https://www.neurology-jp.org/neuro2025/
■Dates: Wednesday, May 21st to Saturday, May 24th, 2025
■Venue:
・Osaka International Convention Center (https://www.gco.co.jp/)
・Rihga Royal Hotel Osaka (https://www.rihga.co.jp/osaka)
■Booth number: Osaka International Convention Center 5F [K-15]
Fushimi Pharmaceutical Co., Ltd. / Proteobridge Co., Ltd. (co-hosted exhibition)
[Contact for this matter]
Proteobridge Co., Ltd.
Public relations officer: Ayaka Sato
Email: sato*proteo-bridge.co.jp
“Please replace the asterisk (*) with an at symbol (@).”